Dr. Winer’s research interests are in the epidemiology and prevention of human papillomavirus (HPV) infections and HPV-related cancers. Her areas of focus include: 1) epidemiology and natural history of HPV infections in populations of young and mid-adult women; 2) use of self-collected vaginal specimens for HPV testing as an adjunct to cervical cancer screening, particularly in underscreened populations; 3) impact of HPV vaccination on HPV infections in young men who have sex with men; 4) strategies for increasing uptake of HPV vaccines in underserved populations; 5) epidemiology of oral HPV infections; and 6) biomarkers for anal cancer screening. Current projects particularly relevant to Population Health include:
Randomized Trial of In-home Cervical Cancer Screening in Underscreened Women: The goal of this NIH-funded implementation science project is to conduct a large, pragmatic randomized controlled trial within Group Health to evaluate an outreach strategy of mailed HPV self-screening kits to reach women who are underscreened for cervical cancer.
HPV Vaccine Impact on Type-Specific and Site-Specific HPV Prevalence in Young Men who have Sex with Men (MSM) in Seattle, Washington: This goal of this CDC-funded project is to determine the real-world impact of HPV vaccination on HPV infections in young MSM – information that can assist in guiding vaccination policies and promotion.
Promoting Human Papillomavirus (HPV) Vaccination in Washington’s East African Communities: The goal of this new CDC-funded project is to evaluate multilevel interventions targeted at adolescents, mothers, and health care providers to increase uptake of HPV vaccines in King County East African communities.
U.S.-based research, primarily in Seattle (at the UW, Group Health, and out in the community)